Loading organizations...
Key people at Woot Math.
Woot Math was founded in 2013 by Krista Marks (Co-Founder & CEO).
Woot Math develops adaptive learning software and interactive tools to enhance mathematics education for students, primarily focusing on foundational concepts such as fractions, decimals, and ratios. The platform employs digital manipulatives, personalized video instruction, and an adaptive engine that analyzes student work to provide targeted support. Additionally, it offers a versatile polling tool for teachers to conduct formative assessments and interactive exercises across various grade levels.
The company was co-founded by Krista Marks, Sean Kelly, Brent Milne, and Jeff Ward, beginning its operations around 2013. Their collective insight centered on the need for research-backed, hands-on approaches to teaching critical math concepts, aiming to improve pre-algebra readiness. The founders envisioned a system that moves beyond traditional methods by allowing students to build conceptual understanding through dynamic, interactive experiences.
Woot Math serves educators and students in grades 3-7 for its adaptive practice, with its polling features applicable to all grades. The company's vision is to empower teachers by providing tools that facilitate deep mathematical understanding and build student confidence through engaging, personalized learning experiences. It continually strives to leverage educational research to support effective instruction and student mastery.
Key people at Woot Math.
Woot Math was founded in 2013 by Krista Marks (Co-Founder & CEO).
Woot Math is an education-technology company that builds research‑backed, adaptive digital tools and interactive manipulatives to help upper‑elementary and middle‑school students (roughly grades 3–8) develop number sense and mastery of fractions and pre‑algebra concepts [5][4].
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick factual pointers: Woot Math is operated by Simbulus, has raised modest venture/ grant funding historically (profiles list ~$2.3M total raised), and its core efficacy claim is supported by NSF‑funded randomized trials and IES/ SBIR success recognition [1][4][8].